Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,798 | 11,315 | 7,106 | 7,832 | 8,535 |
| Receivables | 59,716 | 29,207 | 19,453 | 3,095 | 3,058 |
| Inventories | 21,260 | 16,240 | 12,931 | 9,551 | 6,741 |
| TOTAL | $112,107 | $57,739 | $40,014 | $21,510 | $18,861 |
| Non-Current Assets | |||||
| PPE Net | 10,181 | 10,327 | 10,175 | 10,426 | 5,953 |
| Intangibles | 4,791 | 5,638 | 6,341 | 6,341 | 6,634 |
| Other Non-Current Assets | 11,211 | 22,683 | 27,123 | 2,618 | 3,701 |
| TOTAL | $26,183 | $38,648 | $43,639 | $19,386 | $16,288 |
| Total Assets | $138,290 | $96,388 | $83,654 | $40,896 | $35,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 229 | 4,247 | 4,296 | 311 | 354 |
| Accounts payable and accrued liabilities | 6,053 | 2,958 | 2,714 | 2,447 | 1,431 |
| Accrued Expenses | 10,194 | 3,795 | 5,302 | 5,048 | 4,693 |
| TOTAL | $17,392 | $11,840 | $13,050 | $7,834 | $6,694 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,805 | 3,033 | 3,280 | 3,562 | 1,389 |
| Deferred Revenues | N/A | 6 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 18,359 | 26,751 | 8,255 | 522 | 1,812 |
| TOTAL | $22,015 | $31,032 | $13,021 | $4,102 | $3,233 |
| Total Liabilities | $39,407 | $42,873 | $26,071 | $11,936 | $9,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,077,196 | 1,068,463 | 1,068,273 | 1,013,915 | 1,011,282 |
| Common Shares | 1,077 | 1,069 | 1,068 | 1,014 | 1,011 |
| Retained earnings | -75,831 | -120,704 | -116,389 | -136,498 | -140,060 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $98,883 | $53,515 | $57,583 | $28,960 | $25,222 |
| Total Liabilities And Equity | $138,290 | $96,388 | $83,654 | $40,896 | $35,149 |